Gentamicin aggravates renal injury by affecting mitochondrial dynamics, altering renal transporters expression, and

Mingkang Zhang1, Yan Zhou2, Xiujuan Wang1

  • 1Department of Pharmacy, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, China; School of Pharmacy, Lanzhou University, Lanzhou, Gansu 730000, China.

Toxicology Letters
|July 28, 2025
PubMed

Insights

Gentamicin antibiotic damages kidney cells by impairing mitochondria and promoting apoptosis. Early detection of this drug-induced kidney injury remains a challenge.

Area of Science:

  • Nephrology
  • Toxicology
  • Mitochondrial Biology

Background:

  • Drug-induced nephrotoxicity is a major cause of hospital-acquired acute kidney injury (AKI).
  • Gentamicin, an aminoglycoside antibiotic, is frequently used but limited by kidney toxicity.
  • Mitochondrial dysfunction is a key factor in AKI, making it a therapeutic target.

Purpose of the Study:

  • To investigate the mechanisms of gentamicin-induced nephrotoxicity.
  • To elucidate the role of mitochondrial dysfunction in gentamicin's kidney damage.
  • To explore potential therapeutic strategies for AKI.

Main Methods:

  • In vitro experiments using renal tubular epithelial cells.
  • Dose- and time-dependent exposure to gentamicin.
  • Assessment of mitochondrial structure, membrane potential, and reactive oxygen species (ROS).
  • Analysis of renal transporters, mitochondrial dynamics proteins (OPA1, Mitofusin1/2, DRP1), and apoptosis markers (Bax/Bcl2-Caspase3 pathway).

Main Results:

  • Gentamicin induced dose- and time-dependent damage to renal tubular epithelial cells.
  • Observed were impaired mitochondrial structure, decreased membrane potential, and increased ROS.
  • Gentamicin altered renal transporters, disrupted mitochondrial dynamics, and promoted apoptosis.
  • Standard biomarkers like serum creatinine and blood urea nitrogen (BUN) did not accurately detect early gentamicin-induced kidney injury.

Conclusions:

  • Gentamicin causes nephrotoxicity through mitochondrial dysfunction and apoptosis induction.
  • Current biomarkers are insufficient for early detection of gentamicin-induced kidney injury.
  • Understanding these mechanisms provides a basis for managing gentamicin's clinical use and developing AKI therapies.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.5K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
81
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
363
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.3K